Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
/in Dendritic Cells, International Publications, Prostate Cancer /von 1996-12-01 / Prostate 1996 Dec;29(6):371-80Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group
/in Breast Cancer, Hyperthermia, International Publications /von 1996-07-01 / Int. J. Radiat. Oncol. Biol. Phys. 1996 Jul;35(4):731-44Effect of whole-body hyperthermia on AIDS patients with Kaposi’s sarcoma: a pilot study
/in HIV/AIDS, International Publications /von 1996-03-01 / J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996 Mar;11(3):271-81Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer
/in Hyperthermia, International Publications, Urothelial Carcinoma /von 1996-03-01 / Int. J. Radiat. Oncol. Biol. Phys. 1996 Mar;34(4):887-93Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology
/in Hyperthermia, International Publications, Malignant Lymphoma /von 1996-01-01 / Int J Hyperthermia 1996 Jan-Feb;12(1):3-20Hyperthermia–its actual role in radiation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors
/in Glioblastoma, Hyperthermia, International Publications /von 1995-10-01 / Strahlenther Onkol 1995 Oct;171(10):560-72Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy
/in International Publications, Newcastle Disease Virus, Soft Tissue Sarcoma /von 1994-12-01 / Cancer Res. 1994 Dec;54(23):6017-21Hyperthermia inhibits proliferation and stimulates the expression of differentiation markers in cultured thyroid carcinoma cells
/in International Publications, Thyroid Cancer /von 1994-11-25 / Cancer Lett. 1994 Nov;87(1):65-71Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells
/in International Publications, Micronutrients /von 1994-04-01 / Biol Trace Elem Res 1994 Apr-May;41(1-2):115-27
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
- Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
- Immunotherapy in breast cancer: an overview of current strategies and perspectives